Back
Speaker illustration

undefined undefined undefined

Presentations

Effects of vutrisiran on echocardiographic measures of cardiac structure and function: the HELIOS-B trial

Event: ESC Congress 2025

Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)

Session: Nature Medicine: 2025 highlights

Access
Like
Thumbnail

Prognostic importance of persistent elevations in high-sensitivity troponin T in the early convalescent phase (two weeks) following high-risk myocardial infarction: insights from the PARADISE-MI trial

Event: ESC Congress 2024

Topic: Biomarkers

Session: Diagnostic and prognostic performance of cardiac troponin

Access
Like
Thumbnail

Differences in risk profiles and clinical outcomes according to age in patients with high-risk myocardial infarction: insights from the PARADISE-MI trial

Event: ESC Congress 2024

Topic: Epidemiology, Prognosis, Outcome

Session: Risk stratification models after acute coronary syndrome

Access
Like
Thumbnail

Prognostic importance of NT-proBNP following high-risk myocardial infarction in the PARADISE-MI Trial

Event: ESC Congress 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Troponin and other biomarkers in acute coronary syndromes

Access
Like
Thumbnail

Pulmonary hypertension in heart failure with preserved ejection fraction: the TOPCAT Americas and PARAGON-HF studies

Event: Heart Failure 2021

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Chronic Heart Failure - Pathophysiology and Mechanisms 1

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources